| Literature DB >> 22128289 |
Shawna Leslie Organ1, Ming-Sound Tsao.
Abstract
c-MET is a receptor tyrosine kinase that, after binding with its ligand, hepatocyte growth factor, activates a wide range of different cellular signaling pathways, including those involved in proliferation, motility, migration and invasion. Although c-MET is important in the control of tissue homeostasis under normal physiological conditions, it has also been found to be aberrantly activated in human cancers via mutation, amplification or protein overexpression. This paper provides an overview of the c-MET signaling pathway, including its role in the development of cancers, and provides a rationale for targeting the pathway as a possible treatment option.Entities:
Keywords: MET; c-MET; cancer; hepatocyte growth factor (HGF); receptor tyrosine kinase; signaling
Year: 2011 PMID: 22128289 PMCID: PMC3225017 DOI: 10.1177/1758834011422556
Source DB: PubMed Journal: Ther Adv Med Oncol ISSN: 1758-8340 Impact factor: 8.168